EKR Therapeutics

About:

EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.

Website: http://www.ekrtx.com

Top Investors: NewSpring, GE Healthcare, LLR Partners, MPM Capital, Merrill Lynch

Description:

EKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.